Hospitalist Management of Vaso-Occlusive Pain Crisis in Patients With Sickle Cell Disease Using a Pathway of Care

References

• . Biswas T. Global burden of sickle cell anaemia is set to rise by a third by 2050. BMJ. 2013;347:f4676
   PubMedGoogle Scholar
• . Chang JC, Kan YW. Antenatal diagnosis of sickle cell anaemia by direct analysis of the sickle mutation. Lancet. 1981;2(8256):1127–1129
   PubMed Web of Science ®Google Scholar
• . Hebbel RP. Beyond hemoglobin polymerization: the red blood cell membrane and sickle disease pathophysiology. Blood. 1991;77(2): 214–237
   PubMed Web of Science ®Google Scholar
• . Sun K, Xia Y. New insights into sickle cell disease: a disease of hypoxia. Curr Opin Hematol. 2013;20(3):215–221
   Google Scholar
• . Gee BE. Biologic complexity in sickle cell disease: implications for developing targeted therapeutics. ScientificWorldJournal. 2013;2013:694146
   Google Scholar
• . Taylor LE, Stotts NA, Humphreys J, Treadwell MJ, Miaskowski C. A review of the literature on the multiple dimensions of chronic pain in adults with sickle cell disease. J Pain Symptom Manage. 2010;40(3):416–435
   PubMed Web of Science ®Google Scholar
• . Smith WR, Jordan LB, Hassell KL. Frequently asked questions by hospitalists managing pain in adults with sickle cell disease. J Hosp Med. 2011;6(5):297–303
   PubMedGoogle Scholar
• . Smith WR, Penberthy LT, Bovbjerg VE, . Daily assessment of pain in adults with sickle cell disease. Ann Intern Med. 2008;148(2):94–101
   PubMed Web of Science ®Google Scholar
• . Benjamin LJ, Swinson GI, Nagel RL. Sickle cell anemia day hospital: an approach for the management of uncomplicated painful crises. Blood. 2000;95(4):1130–1136
   PubMed Web of Science ®Google Scholar
• . Ballas SK, Gupta K, Adams-Graves P. Sickle cell pain: a critical reappraisal. Blood. 2012;120(18):3647–3656
   PubMed Web of Science ®Google Scholar
• . Platt OS, Brambilla DJ, Rosse WF, . Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med. 1994;330(23):1639–1544
   PubMed Web of Science ®Google Scholar
• . Gonzalez ER, Bahal N, Hansen LA, . Intermittent injection vs patient-controlled analgesia for sickle cell crisis pain. Comparison in patients in the emergency department. Arch Intern Med. 1991;151(7):1373–1378
   PubMedGoogle Scholar
• . Pack-Mabien A, Labbe E, Herbert D, Haynes J, Jr. Nurses' attitudes and practices in sickle cell pain management. Appl Nurs Res. 2001;14(4):187–192
   PubMed Web of Science ®Google Scholar
• . Morrissey LK, Shea JO, Kalish LA, Weiner DL, Branowicki P, Heeney MM. Clinical practice guideline improves the treatment of sickle cell disease vasoocclusive pain. Pediatr Blood Cancer. 2009;52(3):369–372
   Google Scholar
• . Co JP, Johnson KB, Duggan AK, Casella JF, Wilson M. Does a clinical pathway improve the quality of care for sickle cell anemia? Jt Comm J Qual Saf. 2003;29(4):181–190
   Google Scholar
• . Jayaram A, Nagel RW, Jasty R. Impact of clinical pathway on quality of care in sickle cell patients. J Pediatr Hematol Oncol. 2010;32(7):537–539
   Google Scholar
• . Adams-Graves P, Ostric EJ, Martin M, Richardson P, Lewis JB. Sickle cell hospital unit: a disease-specific model. J Healthc Manag. 2008;53(5):305–315, discussion 16–17
   Google Scholar
• . Weaver SJ, Lubomksi LH, Wilson RF, Pfoh ER, Martinez KA, Dy SM. Promoting a culture of safety as a patient safety strategy: a systematic review. Ann Intern Med. 2013;158(5 Pt 2):369–374
   PubMed Web of Science ®Google Scholar
• . Tanabe P, Hafner JW, Martinovich Z, Artz N. Adult emergency department patients with sickle cell pain crisis: results from a quality improvement learning collaborative model to improve analgesic management. Acad Emerg Med. 2012;19(4):430–438
   PubMed Web of Science ®Google Scholar
• . Miller ST, Kim HY, Weiner D, ; Investigators of the Sickle Cell Disease Clinical Research Network (SCDCRN). Inpatient management of sickle cell pain: a ‘snapshot’ of current practice. Am J Hematol. 2012;87(3):333–336
   PubMed Web of Science ®Google Scholar
• . Feliu MH, Wellington C, Crawford RD, . Opioid management and dependency among adult patients with sickle cell disease. Hemoglobin. 2011;35(5-6):485–494
   PubMed Web of Science ®Google Scholar
• . Glassberg JA, Tanabe P, Chow A, . Emergency provider analgesic practices and attitudes toward patients with sickle cell disease. Ann Emerg Med. 2013;62(4):293–302
   PubMed Web of Science ®Google Scholar
• . Myers M, Eckes EJ. A novel approach to pain management in persons with sickle cell disease. Medsurg Nurs. 2012;21(5):293–298
   PubMedGoogle Scholar
• . Porter J, Feinglass J, Artz N, Hafner J, Tanabe P. Sickle cell disease patients' perceptions of emergency department pain management. J Natl Med Assoc. 2012;104(9-10):449–454
   Google Scholar
• . Brousseau DC, Owens PL, Mosso AL, Panepinto JA, Steiner CA. Acute care utilization and rehospitalizations for sickle cell disease. JAMA. 2010;303(13):1288–1294
   PubMed Web of Science ®Google Scholar
• . Elixhauser A, Steiner C. Readmissions to U.S. Hospitals by Diagnosis, 2010. Statistical Brief #153, Healthcare Cost and Utilization Project. Rockville, MD: Agency for Healthcare Research and Quality; 2013
   Google Scholar
• . Abbas HA, Kahale M, Hosn MA, Inati A. A review of acute chest syndrome in pediatric sickle cell disease. Pediatr Ann. 2013;42(3):115–120
   Google Scholar
• . Smith-Whitley K, Thompson AA. Indications and complications of transfusions in sickle cell disease. Pediatr Blood Cancer. 2012;59(2):358–364
   PubMed Web of Science ®Google Scholar
• . Raphael JL, Mei M, Mueller BU, Giordano T. High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer. 2012;58(4):584–590
   PubMed Web of Science ®Google Scholar
• . Rotter T, Kinsman L, James E, . Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. Cochrane Database Syst Rev. 2010;(3):CD006632
   Google Scholar
• . Frei-Jones MJ, Field JJ, DeBaun MR. Multi-modal intervention and prospective implementation of standardized sickle cell pain admission orders reduces 30-day readmission rate. Pediatr Blood Cancer. 2009;53(3):401–405
   Google Scholar